Repro Med Systems (KRMD) Tops Q2 EPS by 3c ; Offers Guidance

Repro Med Systems (NASDAQ: KRMD) reported Q2 EPS of $0.01, $0.03 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $9.46 million.

GUIDANCE:

Repro Med Systems sees FY2025 revenue of $39.5-40.5 million, versus the consensus of $44.67 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• FTC files amicus brief challenging Amgen's Enbrel patent acquisition
• Apple reportedly cuts jobs in Siri and Vision Pro teams amid AI shift